@article{69c583c8396a4e479b85c7fbcb67503d,
title = "Medical management of primary aldosteronism",
keywords = "aldosterone, amiloride, eplerenone, spironolactone, absence of side effects, adenoma, article, biochemistry, cardiovascular disease, drug megadose, genetic variability, genetics, gynecomastia, hormone synthesis, human, hypertension, libido disorder, primary hyperaldosteronism, renin angiotensin aldosterone system, screening, Adenoma, Adrenal Gland Neoplasms, Aldosterone, Humans, Hyperaldosteronism, Hypertension, Renin",
author = "J. Connell",
note = "Export Date: 19 March 2012 Source: Scopus CODEN: ANENA doi: 10.1016/j.ando.2009.02.013 PubMed ID: 19286154 Language of Original Document: English Correspondence Address: Connell, J.; BHF Glasgow Cardiovascular Research Centre, University of Glasgow, 126 University Place, Glasgow, G12 8TA, United Kingdom; email: j.connell@clinmed.gla.ac.uk Chemicals/CAS: aldosterone, 52-39-1, 6251-69-0; amiloride, 2016-88-8, 2609-46-3; eplerenone, 107724-20-9; spironolactone, 52-01-7; Aldosterone, 52-39-1; Renin, 3.4.23.15 References: Mulatero, P., Stowasser, M., Loh, K.C., Fardella, C.E., Gordon, R.D., Mosso, L., Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents (2004) J Clin Endocrinol Metab, 89, pp. 1045-1050; Young Jr., W.F., Minireview: primary aldosteronism-changing concepts in diagnosis and treatment (2003) Endocrinology, 144, pp. 2208-2213; Mulatero, P., Rabbia, F., Milan, A., Paglieri, C., Morello, F., Chiandussi, L., Drug effects on aldosterone/plasma renin activity ratio in primary aldosteronism (2002) Hypertension, 40, pp. 897-902; Newton-Cheh, C., Guo, C.Y., Gona, P., Larson, M.G., Benjamin, E.J., Wang, T.J., Clinical and genetic correlates of aldosterone-to-renin ratio and relations to blood pressure in a community sample (2007) Hypertension, 49, pp. 846-856; Funder, J.W., Carey, R.M., Fardella, C., Gomez-Sanchez, C.E., Mantero, F., Stowasser, M., Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline (2008) J Clin Endocrinol Metab, 93, pp. 3266-3281; Rossi, G.P., Bernini, G., Caliumi, C., Desideri, G., Fabris, B., Ferri, C., A prospective study of the prevalence of primary aldosteronism in 1125 hypertensive patients (2006) J Am Coll Cardiol, 48, pp. 2293-2300; Barr, M., MacKenzie, S.M., Friel, E.C., Holloway, C.D., Wilkinson, D.M., Brain, N.J.R., Polymorphic variation in the 11 beta-hydroxylase gene associates with reduced 11-hydroxylase efficiency (2007) Hypertension, 49, pp. 113-119; Connell, J.M., MacKenzie, S.M., Freel, E.M., Fraser, R., Davies, E., A lifetime of aldosterone excess: long-term consequences of altered regulation of aldosterone production for cardiovascular function (2008) Endocr Rev",
year = "2009",
doi = "10.1016/j.ando.2009.02.013",
language = "English",
volume = "70",
pages = "177--178",
journal = "Annales d'Endocrinologie",
issn = "0003-4266",
publisher = "Elsevier",
number = "3",
}
